|Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised …|
RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ...
The Lancet 387 (10037), 2507-2520, 2016
|Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review|
ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ...
JAMA psychiatry 73 (3), 292-297, 2016
|Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis|
DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ...
Archives of general psychiatry 62 (1), 19-28, 2005
|The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach|
M Fava, AE Evins, DJ Dorer, DA Schoenfeld
Psychotherapy and psychosomatics 72 (3), 115-127, 2003
|Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists|
DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ...
The Journal of clinical psychiatry 66 (2), 183-194, 2005
|Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence|
AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ...
Biological psychiatry 67 (8), 722-729, 2010
|The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls|
RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ...
Neuropsychopharmacology 33 (3), 480-490, 2008
|Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness|
DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ...
Psychopharmacology 196 (2), 221-232, 2008
|Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study|
DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ...
Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005
|A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia|
AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale
Nicotine & tobacco research 3 (4), 397-403, 2001
|Placebo-controlled trial of glycine added to clozapine in schizophrenia|
AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff
American Journal of Psychiatry 157 (5), 826-828, 2000
|A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia|
AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ...
Journal of clinical psychopharmacology 25 (3), 218-225, 2005
|A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia|
DC Goff, DC Henderson, AE Evins, E Amico
Biological psychiatry 45 (4), 512-514, 1999
|Optimizing real time fMRI neurofeedback for therapeutic discovery and development|
LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ...
NeuroImage: Clinical 5, 245-255, 2014
|A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia|
AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ...
Journal of clinical psychopharmacology 27 (4), 380-386, 2007
|Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial|
AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ...
Jama 311 (2), 145-154, 2014
|Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight|
O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff
The Journal of clinical psychiatry 65 (10), 1372-1376, 2004
|Opioid antagonists for smoking cessation|
SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska
Cochrane Database of Systematic Reviews, 2013
|An exploratory open‐label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia|
DC Henderson, L Kunkel, DD Nguyen, CP Borba, TB Daley, PM Louie, ...
Acta Psychiatrica Scandinavica 113 (2), 142-147, 2006
|A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain|
DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ...
American Journal of Psychiatry 162 (5), 954-962, 2005